These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of the oral form of ondansetron on cerebellar dysfunction. A multi-center double-blind study. Bier JC; Dethy S; Hildebrand J; Jacquy J; Manto M; Martin JJ; Seeldrayers P J Neurol; 2003 Jun; 250(6):693-7. PubMed ID: 12796831 [TBL] [Abstract][Full Text] [Related]
9. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist? Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Späth M; Stratz T; Neeck G; Kötter I; Hammel B; Amberger CC; Haus U; Färber L; Pongratz D; Müller W Scand J Rheumatol; 2004; 33(4):267-70. PubMed ID: 15370724 [TBL] [Abstract][Full Text] [Related]
12. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study. Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501 [TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists--preliminary results. Späth M; Welzel D; Färber L Scand J Rheumatol Suppl; 2000; 113():72-7. PubMed ID: 11028837 [TBL] [Abstract][Full Text] [Related]
14. Prevention of postoperative nausea and vomiting with granisetron and dolasetron in relation to CYP2D6 genotype. Janicki PK; Schuler HG; Jarzembowski TM; Rossi M Anesth Analg; 2006 Apr; 102(4):1127-33. PubMed ID: 16551910 [TBL] [Abstract][Full Text] [Related]
15. The addition of dexamethasone to dolasetron or haloperidol for treatment of established postoperative nausea and vomiting. Rüsch D; Arndt C; Martin H; Kranke P Anaesthesia; 2007 Aug; 62(8):810-7. PubMed ID: 17635430 [TBL] [Abstract][Full Text] [Related]
17. The effect of ondansetron, a 5-HT3 receptor antagonist, in chronic fatigue syndrome: a randomized controlled trial. The GK; Bleijenberg G; Buitelaar JK; van der Meer JW J Clin Psychiatry; 2010 May; 71(5):528-33. PubMed ID: 20122367 [TBL] [Abstract][Full Text] [Related]
18. Failure of ondansetron in treating cerebellar tremor in MS patients--an open-label pilot study. Gbadamosi J; Buhmann C; Moench A; Heesen C Acta Neurol Scand; 2001 Nov; 104(5):308-11. PubMed ID: 11696026 [TBL] [Abstract][Full Text] [Related]
19. Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures. Browning BA; Fort CA; Kemp KD; Shimata MF; Strube MD AANA J; 2004 Apr; 72(2):129-32. PubMed ID: 15098526 [TBL] [Abstract][Full Text] [Related]
20. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study. Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]